bupropion has been researched along with Angina at Rest in 1 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A five-hospital randomized double-blind placebo-controlled trial assessed the safety and efficacy of 12 weeks of sustained-release bupropion (300 mg) or placebo in 248 smokers admitted for acute cardiovascular disease, primarily myocardial infarction and unstable angina." | 5.12 | Bupropion for smokers hospitalized with acute cardiovascular disease. ( Chang, Y; Emmons, KM; McKool, K; Pasternak, RC; Regan, S; Rigotti, NA; Singer, DE; Swartz, S; Thorndike, AN; Torres-Finnerty, N, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rigotti, NA | 1 |
| Thorndike, AN | 1 |
| Regan, S | 1 |
| McKool, K | 1 |
| Pasternak, RC | 1 |
| Chang, Y | 1 |
| Swartz, S | 1 |
| Torres-Finnerty, N | 1 |
| Emmons, KM | 1 |
| Singer, DE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Safety and Efficacy of Sustained-Release (SR) Bupropion for Smokers Hospitalized Smokers With Acute Coronary Heart Disease[NCT00181818] | Phase 4 | 248 participants | Interventional | 1999-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for bupropion and Angina at Rest
| Article | Year |
|---|---|
Bupropion for smokers hospitalized with acute cardiovascular disease.
Topics: Acute Disease; Angina, Unstable; Antidepressive Agents, Second-Generation; Bupropion; Double-Blind M | 2006 |